Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Context and ambiguity: a comment on amending India's patent act

Tools
- Tools
+ Tools

Rangnekar, Dwijen (2007) Context and ambiguity: a comment on amending India's patent act. Working Paper. University of Warwick. Centre for the Study of Globalisation and Regionalisation, Coventry.

[img]
Preview
PDF
WRAP_rangnekar_wp22407.pdf - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader

Download (162Kb)
Official URL: http://www2.warwick.ac.uk/fac/soc/csgr/research/wo...

Abstract

In implementing its patent-related obligations to the TRIPS Agreement, India decided to use the optional additional transitional provisions in Article 65(4). Thus, delaying the introduction of product patents in exempt technologies, notably pharmaceuticals, till 1 January 2005. Ostensibly, this gave it the opportunity to exploit changing circumstances to and emergent views on TRIPS-implementation; in particular exploring new interpretations to residual flexibility in TRIPS and any continuing legal ambiguity in TRIPS obligations. In terms of the latter, the Panel Report in Canada – Patent Protection of Pharmaceutical Products is pertinent in having exhibited rare reticence in stepping back from defining the principle of non-discrimination in Article 27(1), TRIPS Agreement. While maintaining legal ambiguity, this reticence also provides space for law-making and regulatory diversity. The article reviews the three amendments to India’s Patent Act, 1970 and finds mixed use of residual flexibility and some evidence of efforts to explore legal ambiguity. Thus, despite a favourable climate to TRIPS implementation and an active transnational access to medicine campaign, legislators in India have demonstrated a degree of caution. The article concludes that this caution is best explained in terms of deepening ambivalence concerning intellectual property within the government and the changing economic interests of sections of Indian pharma.

Item Type: Working or Discussion Paper (Working Paper)
Subjects: H Social Sciences > HD Industries. Land use. Labor
K Law > K Law (General)
Divisions: Faculty of Social Sciences > Centre for the Study of Globalisation and Regionalisation
Library of Congress Subject Headings (LCSH): Agreement on Trade-Related Aspects of Intellectual Property Rights (1994), Intellectual property -- India, Patent laws and legislation -- India, Patent laws and legislation -- Canada, Pharmaceutical industry -- India, Generic drugs
Series Name: Working papers (University of Warwick. Centre for the Study of Globalisation and Regionalisation)
Publisher: University of Warwick. Centre for the Study of Globalisation and Regionalisation
Place of Publication: Coventry
Date: March 2007
Number: No.224
Number of Pages: 34
Status: Not Peer Reviewed
Access rights to Published version: Open Access
URI: http://wrap.warwick.ac.uk/id/eprint/1884

Request changes to a record

Actions (login required)

View Item View Item

Document Downloads

More statistics for this item...
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us